Skip Navigation LinksHome > July 2010 - Volume 110 - Issue 7 > Rifaximin Receives New Indication
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000383928.15097.ad
Drug Watch

Rifaximin Receives New Indication

Aschenbrenner, Diane S. MS, APRN-BC

Collapse Box

Abstract

* Rifaximin (Xifaxan), a nonsystemic antibiotic usually used to treat traveler's diarrhea, has been approved for the prevention of recurrent hepatic encephalopathy in patients with chronic liver disease.

* The most common adverse effects of rifaximin are peripheral edema, nausea, gas, and headache.

© 2010 Lippincott Williams & Wilkins, Inc.

Login

Article Level Metrics